Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Study Assessing The Safety And Efficacy Of DVS SR For The Treatment Of Vasomotor Symptoms Associated With Menopause

NCT00683800 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00683800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00683800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Study Assessing The Safety And Efficacy Of DVS SR For The Treatment Of Vasomotor Symptoms Associated With Menopause
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
May 31, 2010
Enrollment
2,186 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

vasomotor symptoms